We are systematically dissecting the molecular mechanisms of the neonatal and infant response to infection or vaccination. Based on that knowledge, we are identifying immune modulators that help protect newborns and infants.
Pocket Doc for Pneumonia is a low-cost smartphone tool that uses a light-weight sensor and a data-driven app to assess a child’s vital signs and overall condition, deliver an accurate diagnosis and recommend inexpensive, life-saving treatments such as antibiotics, oxygen and fluids.
A new study from BC Children’s, UBC and an international team of researchers published in the New England Journal of Medicine is the first to identify a rarely-seen type of DNA mutation as the cause of an inherited metabolic disorder.
A recent study from Dr. Pascal Lavoie provides important insights into why preterm babies are more vulnerable to infections than babies born at term. This work could lead to the development of new treatments that jump-start their immune systems.
Dr. Michael Kobor and Dr. Yvonne Lamers, are leading two new international projects investigating the relationship between diet, the epigenome and health thanks to funding from the Canadian Institutes of Health Research (CIHR).
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.